ERBA Diagnostics Mannheim GmbH, Ivax Diagnostics deal

ERBA purchased 72% of the outstanding shares of IVAX

Read the full 91 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE